BE BEAM $29.66 ▲ +0.68% Should I Buy Beam Therapeutics (BEAM)? Finance YouTuber Analysis
VERDICT: BUY 0/100
Get weekly updates on this stock
“The speaker highlights Beam Therapeutics' adenine base editor, which recently received FDA clearance for a clinical trial. They are collaborating…”
Financials
Reported figures · last 5 yearsCall record — BEAM
2 CALLS · 1 BUY / 0 SELL / 1 WATCHCreate a free account to see every call — who, when, at what price.
Each call is dated, linked to the source video, and graded. Free accounts see the full record.
FAQ
Should I buy Beam Therapeutics?
2 finance YouTubers analysed Beam Therapeutics with qualified reasoning — consensus: Buy, average analysis quality 68/100. This is not financial advice; review the individual analyses and sources above.
Are finance YouTubers bullish or bearish on Beam Therapeutics?
Among the channels covering Beam Therapeutics, 1 are buying and 0 are selling or avoiding — overall Buy.
How do you decide what to include for Beam Therapeutics?
Only qualified analyses count: a clear buy/sell stance on Beam Therapeutics with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.